4//SEC Filing
O'Toole David D. 4
Accession 0001181431-09-013281
CIK 0001409012other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:44 PM ET
Size
9.1 KB
Accession
0001181431-09-013281
Insider Transaction Report
Form 4
O'Toole David D.
CFO & Executive VP
Transactions
- Tax Payment
Common Stock
2009-03-02$58.54/sh−319$18,674→ 1,654 total - Exercise/Conversion
Common Stock
2009-03-02+866→ 1,973 total - Exercise/Conversion
Restricted Stock Units
2009-03-02−866→ 2,520 totalFrom: 2009-03-02→ Common Stock (866 underlying)
Footnotes (3)
- [F1]On March 1, 2009, 866 of the restricted stock units that were granted to the reporting person on November 5, 2009 vested, of which 547 was paid out in common stock and 319 units were withheld to satisfy the tax withholding obligation related to such vested units.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Abraxis BioScience common stock.
- [F3]The restricted stock units vest in four equal annual installments commencing on March 1, 2009. Vested shares will be delivered to the reporting person on each vesting date.
Documents
Issuer
Abraxis BioScience, Inc.
CIK 0001409012
Entity typeother
Related Parties
1- filerCIK 0001437047
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:44 PM ET
- Size
- 9.1 KB